These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Receptor tyrosine kinases in osteosarcoma: not just the usual suspects. Rettew AN; Getty PJ; Greenfield EM Adv Exp Med Biol; 2014; 804():47-66. PubMed ID: 24924168 [TBL] [Abstract][Full Text] [Related]
4. Receptor Tyrosine Kinases in Osteosarcoma Treatment: Which Is the Key Target? Tian Z; Niu X; Yao W Front Oncol; 2020; 10():1642. PubMed ID: 32984034 [TBL] [Abstract][Full Text] [Related]
5. Specific tyrosine kinase inhibitors regulate human osteosarcoma cells in vitro. Messerschmitt PJ; Rettew AN; Brookover RE; Garcia RM; Getty PJ; Greenfield EM Clin Orthop Relat Res; 2008 Sep; 466(9):2168-75. PubMed ID: 18607665 [TBL] [Abstract][Full Text] [Related]
12. EMMPRIN expression is associated with metastatic progression in osteosarcoma. Kim HS; Kim HJ; Lee MR; Han I BMC Cancer; 2021 Sep; 21(1):1059. PubMed ID: 34565336 [TBL] [Abstract][Full Text] [Related]
13. Lentivirus-mediated RNAi knockdown of insulin-like growth factor-1 receptor inhibits growth, reduces invasion, and enhances radiosensitivity in human osteosarcoma cells. Wang YH; Wang ZX; Qiu Y; Xiong J; Chen YX; Miao DS; De W Mol Cell Biochem; 2009 Jul; 327(1-2):257-66. PubMed ID: 19229591 [TBL] [Abstract][Full Text] [Related]
14. Targeting receptor tyrosine kinases in osteosarcoma and Ewing sarcoma: current hurdles and future perspectives. Fleuren ED; Versleijen-Jonkers YM; Boerman OC; van der Graaf WT Biochim Biophys Acta; 2014 Apr; 1845(2):266-76. PubMed ID: 24582852 [TBL] [Abstract][Full Text] [Related]
15. Increased expression of insulin-like growth factor-1 receptor is correlated with worse survival in canine appendicular osteosarcoma. Maniscalco L; Iussich S; Morello E; Martano M; Gattino F; Miretti S; Biolatti B; Accornero P; Martignani E; Sánchez-Céspedes R; Buracco P; De Maria R Vet J; 2015 Aug; 205(2):272-80. PubMed ID: 25257352 [TBL] [Abstract][Full Text] [Related]
16. Insulin-like growth factor-I receptor tyrosine kinase inhibitor cyclolignan picropodophyllin inhibits proliferation and induces apoptosis in multidrug resistant osteosarcoma cell lines. Duan Z; Choy E; Harmon D; Yang C; Ryu K; Schwab J; Mankin H; Hornicek FJ Mol Cancer Ther; 2009 Aug; 8(8):2122-30. PubMed ID: 19638450 [TBL] [Abstract][Full Text] [Related]
17. miR-199a-3p negatively regulates the progression of osteosarcoma through targeting AXL. Tian R; Xie X; Han J; Luo C; Yong B; Peng H; Shen J; Peng T Am J Cancer Res; 2014; 4(6):738-50. PubMed ID: 25520864 [TBL] [Abstract][Full Text] [Related]
18. Increased expression of insulin-like growth factor-1 receptor is correlated with tumor metastasis and prognosis in patients with osteosarcoma. Wang YH; Han XD; Qiu Y; Xiong J; Yu Y; Wang B; Zhu ZZ; Qian BP; Chen YX; Wang SF; Shi HF; Sun X J Surg Oncol; 2012 Mar; 105(3):235-43. PubMed ID: 21866554 [TBL] [Abstract][Full Text] [Related]
19. R1507, a fully human monoclonal antibody targeting IGF-1R, is effective alone and in combination with rapamycin in inhibiting growth of osteosarcoma xenografts. Kolb EA; Kamara D; Zhang W; Lin J; Hingorani P; Baker L; Houghton P; Gorlick R Pediatr Blood Cancer; 2010 Jul; 55(1):67-75. PubMed ID: 20486173 [TBL] [Abstract][Full Text] [Related]
20. Multiple receptor tyrosine kinases are expressed in adult rat retinal ganglion cells as revealed by single-cell degenerate primer polymerase chain reaction. Lindqvist N; Lönngren U; Agudo M; Näpänkangas U; Vidal-Sanz M; Hallböök F Ups J Med Sci; 2010 Feb; 115(1):65-80. PubMed ID: 20187850 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]